Adaptation and validation of the Glasgow Antipsychotic Side-Effect Scale in Bangladesh
East Asian Archives of Psychiatry · 2025
DOI: 10.12809/eaap2544 ↗At a glance
Validierungsstudie in East Asian Archives of Psychiatry, 2025. Written by T I Zahangir and 4 co-authors. Institution: Department of Psychiatry, National Institute of Mental Health, Dhaka, Bangladesh. Major MEDLINE topics: Antipsychotic Agents, Schizophrenia, Psychiatric Status Rating Scales. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
OBJECTIVE: This study aimed to adapt and validate the Glasgow Antipsychotic Side-Effect Scale (GASS) in Bangla. METHODS: Patients aged ≥18 years with a psychiatric disorder who were currently taking antipsychotics were recruited from a tertiary care psychiatric hospital using convenience sampling. Additionally, patients aged ≥18 years with a psychiatric disorder who had not received any antipsychotic medications in the past 6 months were recruited as controls. Participants were assessed using the newly adapted GASS Bangla. Internal consistency was assessed using McDonald's omega. Principal component analysis with varimax rotation was used to determine the factor structure. Discriminant validity was examined. RESULTS: In total, 153 male and 67 female patients (mean age, 27.8 years) who were receiving antipsychotic medications were included. The most common diagnoses were schizophrenia spectrum disorders (49.1%) and bipolar disorders (46.8%). The median duration of illness was 36 months, and the median duration of antipsychotic medication was 4 months. Additionally, 29 male and 21 female controls (mean age, 30.2 years) were included. The mean GASS Bangla score of the patients was 13.3 ± 8.4. Among the 220 patients, 181 (82.3%) reported absent or mild adverse effects, 34 (15.5%) reported moderate adverse effects, and five (2.3%) reported severe adverse effects. In contrast, all controls reported either absent or mild adverse effects. Patients taking antipsychotic medication had higher median GASS Bangla scores than controls (12 vs 2, p < 0.001), supporting the scale's discriminant validity. Internal consistency of the GASS Bangla was moderate (McDonald's omega = 0.604). Factor loadings ranged from 0.040 to 0.573, with most items loading above the conventional threshold of 0.30. Principal component analysis revealed a seven-factor structure that explained 58.9% of the total variance. CONCLUSION: The GASS Bangla is a user-friendly instrument for use as a screening tool. Despite moderate internal consistency, its clinical relevance and strong discriminant validity support its application in clinical practice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Psychiatry, National Institute of Mental Health, Dhaka, Bangladesh.
- Department of Psychiatry, Faridpur Medical College, Faridpur, Bangladesh.
- Department of Psychiatry, Chittagong Medical College, Chittagong, Bangladesh.
- Department of Child & Adolescent Psychiatry, National Institute of Mental Health, Dhaka, Bangladesh.
- Department of Psychiatry, Pabna Mental Hospital, Pabna, Bangladesh.
Cite
APA
Zahangir, T. I., Ahmed, H. U., Datta, J., Afrin, S., & Sarkar, A. A. (2025). Adaptation and validation of the Glasgow Antipsychotic Side-Effect Scale in Bangladesh. East Asian Archives of Psychiatry. https://doi.org/10.12809/eaap2544
Vancouver
Zahangir TI, Ahmed HU, Datta J, Afrin S, Sarkar AA. Adaptation and validation of the Glasgow Antipsychotic Side-Effect Scale in Bangladesh. East Asian Archives of Psychiatry. 2025. doi:10.12809/eaap2544
BibTeX
@article{Zahangir2025,
author = {Zahangir, T I and Ahmed, H U and Datta, J and Afrin, S and Sarkar, A A},
title = {Adaptation and validation of the Glasgow Antipsychotic Side-Effect Scale in Bangladesh},
journal = {East Asian Archives of Psychiatry},
year = {2025},
doi = {10.12809/eaap2544}
}
EUVIMED